These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1687763)

  • 1. EEG evidence that morphine and an enkephalin analog cross the blood-brain barrier.
    Kastin AJ; Pearson MA; Banks WA
    Pharmacol Biochem Behav; 1991 Dec; 40(4):771-4. PubMed ID: 1687763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to morphine bradycardia in the rat.
    Kiang JG; Dewey WL; Wei ET
    J Pharmacol Exp Ther; 1983 Jul; 226(1):187-91. PubMed ID: 6864538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection by opioids against gastric lesions caused by necrotizing agents.
    Ferri S; Speroni E; Candeletti S; Cavicchini E; Romualdi P; Govoni P; Marchini M
    Pharmacology; 1988; 36(2):140-4. PubMed ID: 3353441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary naltrexone reverses morphine-induced behaviors.
    Mickley GA; Stevens KE; Galbraith JA
    Physiol Behav; 1985 Aug; 35(2):249-53. PubMed ID: 4070392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and peripheral sites of action for the protective effect of opioids of the rat stomach.
    Ferri S; Arrigo-Reina R; Candeletti S; Costa G; Murari G; Speroni E; Scoto G
    Pharmacol Res Commun; 1983 Apr; 15(4):409-18. PubMed ID: 6306698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys.
    Platt DM; Rowlett JK; Izenwasser S; Spealman RD
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1030-9. PubMed ID: 14634035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral receptors mediate the aversive conditioning effects of morphine in the rat.
    Bechara A; Zito KA; van der Kooy D
    Pharmacol Biochem Behav; 1987 Oct; 28(2):219-25. PubMed ID: 2825220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies.
    Kastin AJ; Ehrensing RH; Olson RD; Coy DH
    Int J Neurol; 1980; 14(2-4):205-9. PubMed ID: 6152908
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
    Pazos A; Flórez J
    Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
    Morelli M; Di Chiara G
    Brain Res; 1985 Aug; 341(2):350-9. PubMed ID: 2864100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1.
    Banks WA; Kastin AJ; Harrison LM; Zadina JE
    Neurotoxicol Teratol; 1996; 18(6):711-5. PubMed ID: 8947949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.